Display Settings:

Format

Send to:

Choose Destination
    Cell Cycle. 2005 Oct;4(10):1360-3. Epub 2005 Oct 5.

    Cardiomyocyte proliferation: a platform for mammalian cardiac repair.

    Source

    Howard Hughes Medical Institute, Boston, Massachusetts 02115, USA. engel@enders.tch.harvard.edu

    Abstract

    Permanent loss of heart muscle cells, cardiomyocytes, is a major mechanism resulting in ventricular dysfunction and heart failure. Potential solutions to this problem could be either to stimulate the heart to generate new cells by inducing existing cardiomyocytes to divide or to activate or deliver stem cells/ progenitor cells to multiply and subsequently differentiate into cardiomyocytes. Utilizing in vitro and in vivo approaches, p38 MAP kinase has recently been identified as a key negative regulator of cardiomyocyte proliferation. This work provides strong evidence that adult mammalian cardiomyocytes can divide. This review discusses the potential of the induction of mammalian cardiomyocyte proliferation as a therapeutic strategy for myocardial repair.

    PMID:
    16138008
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for Landes Bioscience

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk